newsfilter
← Latest News
GlobeNewswire·

Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum

  • Rapid Micro Biosystems (NASDAQ: RPID) will participate in the KeyBanc Capital Markets Healthcare Forum.
  • The company is scheduled for a virtual Q&A session with a host analyst on Tuesday, March 17, 2026, at 11:15 a.m. Eastern Time.
  • A live webcast of the event will be available on the company's investor relations website at https://investors.rapidmicrobio.com/ and will be archived for replay.
  • Rapid Micro Biosystems provides automation solutions for manufacturing healthcare products including biologics, vaccines, cell & gene therapies, & sterile injectables.
  • The company's flagship Growth Direct system automates microbial quality control testing to improve operational efficiency, data integrity, & decision-making speed.
  • The company is headquartered in Lexington, Massachusetts, with U.S. manufacturing in Lowell, Massachusetts, & global locations in Switzerland, Germany, & the Netherlands.